Valeant Pharma (VRX) sued in New York Federal court over alleged overcharges - Reuters

August 29, 2016 1:57 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

(Updated - August 29, 2016 2:01 PM EDT)

Valeant Pharma (NYSE: VRX) was sued in New York Federal court over alleged overcharges, according to Reuters. The lawsuit was brought on behalf of so-called third party payors over alleged overcharges from January 2013 to October 2015.

Plaintiffs include New York hotel trade group's health benefits fund, and detectives endowment association of New York City, the report noted.

The lawsuit accuses Valeant of violating U.S. racketeer influenced and corrupt organizations act, or RICO, and seeks class action status, unspecified compensatory and triple damages.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Litigation, Short Sales, Trader Talk

Add Your Comment